Recombinant horse allergen and mutant and preparation methods and applications thereof
A technology of allergens and mutants, applied in the field of genetic engineering, can solve problems such as limitations in the application of immunotherapy, induction of allergies, slow effect, etc., and achieve the effect of reducing allergenicity and reducing binding performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Example 1 Cloning and Expression of Recombinant Equine Allergen
[0035] (1) Determination of the nucleic acid sequence of the recombinant equine allergen: Obtain the nucleic acid sequence of the natural equine allergen Equ-c1 (GenBank accession number U70823.1) from the NCBI database, and add affinity for purification to the C-terminus of the sequence Tag 6*HIS, STREPII or S protein, and then add restriction sites such as Nde I, Eco RI, Xho I, and Pst I to the N-terminus and C-terminus of the sequence, respectively, to obtain the target gene fragment Q9PL of the recombinant horse allergen.
[0036] (2) According to the codon preference of Escherichia coli, the codon optimization of the nucleic acid sequence of the target gene Q9PL made the target gene more suitable for expression in the host bacteria. After optimization, the GC content was 35-65%, and the original amino acid sequence remained unchanged. , as shown in SEQ ID NO:1.
[0037] (3) Artificially synthesize...
Embodiment 2
[0044] Example 2 Antigen Epitope Analysis and Mutation Site Determination of Recombinant Equine Allergen
[0045] (1) Using online software platforms including SYFPEITHI, MHCPred, SYFPEITHI, BIMAS, NetMHCⅡ, MHC-THREAD, EpiPredict, HLA-DR4 binding, ProPred, RankPep, SVMHC, PREDEP, PREDICT, etc. to analyze the antigenic index of amino acid sequences of recombinant horse allergens for analysis. Based on the analysis of various software, the results showed that the antigenic value of the 45-75, 113-136, 146-169 regions in the amino acid sequence of the recombinant horse allergen was higher.
[0046] (2) Carry out amino acid substitutions for one or more sites with relatively high antigenic value to weaken the antigenicity. The above-mentioned antigenicity analysis is performed on the amino acid sequence after antigenic modification, and so on, and the mutation sites with significantly reduced antigenicity are screened out.
Embodiment 3
[0047] Example 3 Construction of recombinant horse allergen mutants
[0048] (1) For the identified mutation site, design mutant primers according to the method provided by the mutation kit. The Tm value is generally required to be greater than 78°C, and the primer length is more suitable between 25-45 bases.
[0049] (2) According to the requirements of the mutation kit, the recombinant expression plasmid of the recombinant horse allergen was used as a template for mutation PCR.
[0050] (3) After digesting the PCR product with the enzyme provided in the kit, transform the competent cells, pick positive clones, and sequence to check whether the mutation is successful.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com